United States

StemLife Bhd (STLI.KL)

STLI.KL on Kuala Lumpur Stock Exchange

3 May 2016
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for STLI.KL


StemLife Berhad is a Malaysia-based company engaged in investment holding and provision of collection, testing, processing and preservation of umbilical cord blood stem cells (UCBSC), umbilical cord tissues (UCT) and peripheral blood stem cells (PBSC) services. The Company's other activities include stem cell therapy and... (more)
No analyst recommendations are available for STLI.KL.


Beta: 1.40
Market Cap(Mil.): RM118.80
Shares Outstanding(Mil.): 247.50
Dividend: --
Yield (%): 6.25


  STLI.KL Industry Sector
P/E (TTM): -- 51.36 44.92
EPS (TTM): -0.00 -- --
ROI: -2.69 6.14 12.47
ROE: -2.69 9.61 13.34
Search Stocks

Earnings vs. Estimates

No consensus analysis data available.

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
Provider : Wright Reports
Provider : Thomson Reuters Stock Report
Provider : Thomson Reuters Stock Report
Provider : Thomson Reuters Stock Report

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks